---
title: "Weekly Recap | Tango Therapeutics +2.45%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301472665.md"
description: "Tango Therapeutics (TNGX) rose 2.45% this week to close at $23.81, outpacing the S&P 500 by about 1.3 percentage points. The week was choppy, with a 13.48% swing from high to low. Shares pulled back early in the week, hitting an intraday low of $20.98 on Thursday — the bottom of the 60-day range — before rebounding on Friday to finish near the week’s high. There was no major company catalyst this week."
datetime: "2026-10-10T07:54:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301472665.md)
  - [en](https://longbridge.com/en/news/301472665.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301472665.md)
generator: "portal-rs"
---

# Weekly Recap | Tango Therapeutics +2.45%, most brokers rate it buy

## The Week

Tango Therapeutics (TNGX) rose 2.45% this week to close at $23.81, outpacing the S&P 500 by about 1.3 percentage points. The week was choppy, with a 13.48% swing from high to low. Shares pulled back early in the week, hitting an intraday low of $20.98 on Thursday — the bottom of the 60-day range — before rebounding on Friday to finish near the week’s high. There was no major company catalyst this week.

## Analyst Ratings

Of the 12 firms covering TNGX, 10 rate it buy, 1 rate it overweight and 1 rate it hold, with no underweight or sell ratings. The consensus rating is strong buy, and the consensus target sits at $45.18, about 89.8% above the latest price. Targets range from $24 to $69, pointing to wide disagreement. Within the biotech sector, TNGX ranks 98th out of 508 names by analyst rating.

## The Week Ahead

US CPI and core CPI land on Wednesday, with NFIB small business confidence and existing home sales due on Tuesday. TNGX has no scheduled earnings next week, but macro data could shift appetite for biotech names.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [TNGX.US](https://longbridge.com/en/quote/TNGX.US.md)

## Related News & Research

- [Tango Therapeutics President, R&D Crystal Adam disposes of USD 661,799 in common shares](https://longbridge.com/en/news/300970303.md)
- [Tango Therapeutics Principal Accounting Officer Jessica Newcomb disposes of USD 196,558.19 in common shares](https://longbridge.com/en/news/300084734.md)
- [ANALYSIS-Market selloff, rising rates test AI data centre deal boom](https://longbridge.com/en/news/301979561.md)
- [Sandisk Stock Is Falling Thursday: What's Going On?](https://longbridge.com/en/news/301982790.md)
- [Peter Schiff Warns Trump’s ‘Booming’ Stock Market Boast Is a Mirage: 479 Stocks Hit 52-Week Lows on Wednesday, While Only 60 Set Highs](https://longbridge.com/en/news/301958076.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**